Compare LYG & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LYG | SYK |
|---|---|---|
| Founded | 1695 | 1941 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.5B | 125.7B |
| IPO Year | 2012 | 1994 |
| Metric | LYG | SYK |
|---|---|---|
| Price | $6.05 | $331.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | N/A | ★ $415.57 |
| AVG Volume (30 Days) | ★ 13.0M | 2.2M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.73% | 1.12% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 5.23 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $13.36 | $9.80 |
| Revenue Next Year | $7.28 | $8.44 |
| P/E Ratio | ★ $62.13 | $63.22 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $4.20 | $281.00 |
| 52 Week High | $6.34 | $396.86 |
| Indicator | LYG | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 49.09 |
| Support Level | $5.84 | $328.23 |
| Resistance Level | $6.18 | $335.45 |
| Average True Range (ATR) | 0.07 | 8.63 |
| MACD | -0.02 | -1.85 |
| Stochastic Oscillator | 39.89 | 29.48 |
Lloyds is a retail and commercial bank headquartered in the United Kingdom. The bank operates via three business segments: retail, commercial banking, and insurance and wealth. In retail, Lloyds offers primarily mortgages (66% of its loan portfolio), credit cards, and current accounts to its customers. Its commercial banking operation provides lending, transaction banking, working capital management, and debt capital market services to large companies and financial institutions in the UK. Insurance and wealth round out the product lineup with life and property insurance as well as pension solutions and high-net-worth asset management services.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.